Concepedia

Memetcan Alacakaptan

MA

Statistics

Publications

5

Citations

339

H-Index

5

Active since

2006

Affiliations

Research Institute of Molecular Pathology(Current)

Medical University of Vienna

Memetcan Alacakaptan is an author at Research Institute of Molecular Pathology specializing in cancer cell signaling, metastasis, and medicine.

Publications per year

2006–2014

5

Publications

5

ILEI: A cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells

Thomas Waerner, Memetcan Alacakaptan, Ido H Tamir et al. · Cancer Cell · 2006 · 186 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

Annexin A1 attenuates EMT and metastatic potential in breast cancer

Sabine Maschler, Christoph A. Gebeshuber, Memetcan Alacakaptan et al. · EMBO Molecular Medicine · 2010 · 84 citations · Full text

Medicine, Molecular Biology, Oncology +17

Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen–urokinase plasminogen activator receptor system–regulated secretion during breast cancer progression

Agnes Csiszar, Betül Kutay, Silvia Wirth et al. · Breast Cancer Research · 2014 · 26 citations · Full text

Medicine, Molecular Biology, Oncology +15

Diverging fates of cells of origin in acute and chronic leukaemia

Boris Kovačic, Andrea Hoelbl‐Kovacic, Gabriele Litos et al. · EMBO Molecular Medicine · 2012 · 23 citations · Full text

Life Sciences, Cell Biology, Hematology +12

BI 5700, a Selective Chemical Inhibitor of I B Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression

Margit A. Huber, Helena J. Maier, Memetcan Alacakaptan et al. · Genes & Cancer · 2010 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 5